FIELD: medicine.
SUBSTANCE: skin graft is simulated in laboratory animals on the second experimental day. Dihydroquercetin is administered intragastrically in a daily dose of 5.5 mg/kg from the first day every 46 hours of the experiment.
EFFECT: increasing the skin graft survival in the reduced circulation environment by activating the pre-conditioning process.
1 ex, 1 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD FOR DERMAL FLAP SURVIVAL GROWTH IN REDUCED CIRCULATION WITH RESVERATROL | 2012 | 
 | RU2511061C1 | 
| METHOD FOR DERMAL FLAP SURVIVAL GROWTH IN REDUCED CIRCULATION WITH L-NORVALINE | 2012 | 
 | RU2513619C1 | 
| METHOD FOR DERMAL FLAP SURVIVAL GROWTH IN REDUCED CIRCULATION WITH MINOXIDIL | 2012 | 
 | RU2497201C1 | 
| METHOD FOR PHARMACOLOGICAL STIMULATION OF PEDICLE SKIN FLAP SURVIVAL WITH NICORANDYL | 2012 | 
 | RU2507598C1 | 
| METHOD FOR DERMAL FLAP SURVIVAL GROWTH IN REDUCED CIRCULATION WITH SILDENAFIL | 2012 | 
 | RU2498414C1 | 
| METHOD FOR STIMULATING NEOANGIOGENESIS IN ISCHEMIC SKELETAL MUSCLE | 2014 | 
 | RU2547692C1 | 
| METHOD OF PHARMACOLOGICAL CORRECTION OF ISCHEMIC TISSUES SURVIVAL RATE IN REDUCED BLOOD CIRCULATION ENVIRONMENT | 2010 | 
 | RU2438190C1 | 
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION IN ADMA-LIKE GESTOSIS MODEL IN EXPERIMENT | 2012 | 
 | RU2507594C2 | 
| METHOD FOR IMPROVING SURVIVAL RATE OF ISCHEMIC TISSUES (ISOLATED SKIN PEDICLE FLAP) IN REDUCED BLOOD CIRCULATION | 2010 | 
 | RU2429547C1 | 
| METHOD OF PHARMACOLOGICAL CORRECTION OF ISCHEMIA OF SKELETAL MUSCLE WITH RESVERATROL | 2012 | 
 | RU2518965C1 | 
Authors
Dates
2015-04-10—Published
2014-02-13—Filed